Homes and Property | Home Page

'The Plumber' sells Cyprotex stake

PAUL Davidson, the controversial entrepreneur known in the City as 'the Plumber', today made his exit from Cyprotex, the company that gained him notoriety when its flotation was underpinned by a £5m spread bet.

Davidson sold the 29.9% stake to Nordan Holdings at 10p a share, grossing £2.7m. The share price rose 1 1/4p to 13 1/4p after the deal.

Nordan is an investment vehicle in which, Cyprotex says, Davidson 'has a partial economic interest'. However, it is controlled by Auback Capital Partners, a private investment vehicle in which Davidson has no legal or beneficial interest.

The man behind the deal and a leading shareholder in the new company is Robert Atwater, who becomes chairman and chief executive of Cyprotex.

The Macclesfield drug testing software group will benefit from his contacts built up during a 15-year career in the pharmaceutical and biotech industries on both sides of the Atlantic.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Sign up you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy notice .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in

MORE ABOUT

Bio-technology
Drug Testing
Investment
Macclesfield
Medicine
Pharmaceuticals